NaviMed Partners
QuietFiled to raiseArlington, VAHealthcare, Biotechnology, PharmaceuticalsLast fund filed 2024
3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| NaviMed Partners IIIFiled to raise in 2024, with no closing reported yet. | 2024 | Indefinite | $0 | 0 |
| NaviMed Partners II | September 2019 | Indefinite | $166M | 28 |
| NaviMed Partners Executive Fund | February 2013 | Indefinite | $4.1M | 9 |
| NaviMed Partners | February 2013 | $108M | $108M | 25 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
5 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Bijan Salehizadeh | Quiet | Biotech & pharma, Enterprise software, Fintech | 7 |
Classified sectors of NaviMed Partners’s own portfolio companies, based on 10 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Versant Venture Capital | 3 | AcuFocus, NEOVISTA, OPGEN |
| SV Life Sciences | 2 | AcuFocus, AQUESYS |
| Biomatics Capital Partners | 1 | Aledade |
| Causeway Media Partners |
| 0 |
| Brian Canann | Quiet | Healthcare services | 1 | 0 |
| Kun Seung LeeNot on the current fund | Quiet | None listed | 0 | 0 |
| Ryan RossNot on the current fund | Quiet | None listed | 2 | 0 |
| Ryan Schwarz | Quiet | Digital health, Medical devices, Healthcare services | 5 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of NaviMed Partners’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| 1 |
| AURIS SURGICAL ROBOTICS |
| Gran Paradiso Capital Partners | 1 | HYPERION THERAPEUTICS |
| Heritage Group (Healthcare Innovation) | 1 | Lumere |
| Highland Capital Partners | 1 | OPGEN |
| Lux Capital | 1 | AURIS SURGICAL ROBOTICS |
| Mithril | 1 | AURIS SURGICAL ROBOTICS |
| Sofinnova Venture Partners | 1 | HYPERION THERAPEUTICS |
| Sonder Futures | 1 | AURIS SURGICAL ROBOTICS |
A shared board seat: a company where filings name a NaviMed Partners partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.